Evaluation of the safety, biodistribution, dosimetry of [ 18 F]AlF-NOTA-LM3 and head-to-head comparison with [ 68 Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.
Meixi LiuChao RenHaiqiong ZhangYuwei ZhangZhenghai HuangRu JiaYuejuan ChengChunmei BaiQiang XuWenjia ZhuLi HuoPublished in: European journal of nuclear medicine and molecular imaging (2024)
ClinicalTrials.gov identifier NCT06056362.